Cargando…

Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis

This meta-analysis explored the safety and effectiveness of mucolytics as an add-on treatment for chronic obstructive pulmonary disease (COPD) exacerbations. Based on a pre-registered protocol and following Cochrane methods, we systematically searched for relevant randomised or quasi-randomised cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papadopoulou, Efthymia, Hansel, Jan, Lazar, Zsofia, Kostikas, Konstantinos, Tryfon, Stavros, Vestbo, Jørgen, Mathioudakis, Alexander G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879332/ https://www.ncbi.nlm.nih.gov/pubmed/36697209 http://dx.doi.org/10.1183/16000617.0141-2022

Ejemplares similares

Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits
por: Mathioudakis, Alexander G, et al.
Publicado: (2020)

Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler(®) Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study
por: Steiropoulos, Paschalis, et al.
Publicado: (2021)

Mucolytic Agents and Statins Use is Associated with a Lower Risk of Acute Exacerbations in Patients with Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap
por: Su, Vincent Yi-Fong, et al.
Publicado: (2018)

Prevalence and clinical implications of respiratory viruses in stable chronic obstructive pulmonary disease (COPD) and exacerbations: a systematic review and meta-analysis protocol
por: Kefala, Anastasia M, et al.
Publicado: (2020)

Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
por: Mathioudakis, Alexander G., et al.
Publicado: (2017)

Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial
por: Koppitz, Martin, et al.
Publicado: (2016)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Assessing Treatment Success or Failure as an Outcome in Randomised Clinical Trials of COPD Exacerbations. A Meta-Epidemiological Study
por: Mathioudakis, Alexander G., et al.
Publicado: (2021)

Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
por: Mathioudakis, Alexander G., et al.
Publicado: (2020)

A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
por: Mathioudakis, Alexander G., et al.
Publicado: (2019)

Role of mucolytics in the management of COPD
por: Poole, Phillippa J
Publicado: (2006)

A conservative treatment for chronic obstructive sialoadenitis by intraductal instillation of mucolytic, steroids and antibiotic solution
por: Lorusso, Francesco, et al.
Publicado: (2021)

Cardiovascular Disease and Chronic Obstructive Pulmonary Disease: Adding a Third Dimension to the ABE Global Initiative for Chronic Obstructive Lung Disease 2023 Chronic Obstructive Pulmonary Disease Classification
por: Kostikas, Konstantinos, et al.
Publicado: (2023)

Fixed Triple Therapy in Chronic Obstructive Pulmonary Disease and Survival. Living Better, Longer, or Both?
por: Vestbo, Jørgen
Publicado: (2020)

A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases
por: Addante, Annalisa, et al.
Publicado: (2023)

Capsule Commentary on Bremmer et. al., Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations
por: Mathioudakis, Alexander G.
Publicado: (2018)

Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
por: Mathioudakis, Alexander G., et al.
Publicado: (2019)

International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials
por: Calverley, Peter M. A., et al.
Publicado: (2022)

Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine
por: Rogliani, Paola, et al.
Publicado: (2019)

Chronic obstructive pulmonary disease exacerbation frequency and severity
por: Stafyla, Eirini, et al.
Publicado: (2013)

Repurposing the mucolytic agent ambroxol for treatment of sub-acute and chronic ischaemic stroke
por: Patzwaldt, Kristin, et al.
Publicado: (2023)

Mucolytic treatment of chronic rhinosinusitis in a murine model of primary ciliary dyskinesia
por: Yin, Weining, et al.
Publicado: (2023)

Pulmonary biomarkers in COPD exacerbations: a systematic review
por: Koutsokera, Angela, et al.
Publicado: (2013)

Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action
por: Pace, Elisabetta, et al.
Publicado: (2022)

Exacerbations of Chronic Obstructive Pulmonary Disease
por: Garvey, Christine, et al.
Publicado: (2012)

The Chronic Obstructive Pulmonary Disease Exacerbation
por: Sherk, Peter A., et al.
Publicado: (2000)

Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhou, Xianghui, et al.
Publicado: (2015)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
por: Vogelmeier, Claus F, et al.
Publicado: (2018)

Was the implementation strategy of the ProACT trial adequately proactive?
por: Mathioudakis, Alexander G., et al.
Publicado: (2019)

Efficacy of mucolytics and steam therapy in the management of sinusitis among Indians
por: S Balakrishnan, Rajalakshmi, et al.
Publicado: (2023)

Chronic obstructive pulmonary disease and COVID-19: interrelationships
por: Singh, Dave, et al.
Publicado: (2022)

Combined Pulmonary Fibrosis and Emphysema: Comparative Evidence on a Complex Condition
por: Calaras, Diana, et al.
Publicado: (2023)

Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Segal, Leopoldo N., et al.
Publicado: (2015)

Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Publicado: (2007)

CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Acute Exacerbations
por: Wedzicha, J.A., et al.
Publicado: (2006)

Management of Exacerbations in Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2012)

Association of TLR4-T399I Polymorphism with Chronic Obstructive Pulmonary Disease in Smokers
por: Speletas, Matthaios, et al.
Publicado: (2009)

Prognostic Value of C-Reactive Protein, Leukocytes, and Vitamin D in Severe Chronic Obstructive Pulmonary Disease
por: Moberg, Mia, et al.
Publicado: (2014)

Prevention of COPD exacerbations: medications and other controversies
por: Vestbo, Jørgen, et al.
Publicado: (2015)

Pulmonary Strongyloidiasis Masquerading as Exacerbation of Chronic Obstructive Pulmonary Disease
por: Pradhan, Gourahari, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7ls9fceuch1kv35vu3lr4d88cu